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Abstract
Background: Antibiotic resistance in bacterial infections is a growing threat to public health. Recent evidence
shows that when exposed to stressful conditions, some bacteria perform higher rates of horizontal gene transfer
and mutation, and thus acquire antibiotic resistance more rapidly.
Methods: We incorporate this new notion into a mathematical model for the emergence of antibiotic multi-
resistance in a hospital setting.
Results: We show that when stress has a considerable effect on genetic variation, the emergence of antibiotic
resistance is dramatically affected. A strategy in which patients receive a combination of antibiotics (combining) is
expected to facilitate the emergence of multi-resistant bacteria when genetic variation is stress-induced. The
preference between a strategy in which one of two effective drugs is assigned randomly to each patient (mixing),
and a strategy where only one drug is administered for a specific period of time (cycling) is determined by the
resistance acquisition mechanisms. We discuss several features of the mechanisms by which stress affects variation
and predict the conditions for success of different antibiotic treatment strategies.
Conclusions: These findings should encourage research on the mechanisms of stress-induced genetic variation
and establish the importance of incorporating data about these mechanisms when considering antibiotic
treatment strategies.
Keywords: stress induced mutagenesis, HGT, antibiotic resistance, evolution, mathematical model
Background
Bacterial resistance to antibiotics has accompanied the
introduction of new antibiotics since shortly after peni-
cillin was first introduced [1] and is currently considered
a major health issue [2,3]. The implications of infection
with antibiotic-resistant bacteria include increased mor-
tality rates, prolonged hospitalization and higher cost of
treatment [1,4,5]. A particularly dangerous prospect of
the continued evolution of drug resistance in bacteria is
the creation of new, multidrug resistant bacteria. Such
bacterial strains are already present in several species of
bacteria [3,6] and treating them is more difficult and
often accompanied by a period of ineffective treatment,
resulting in increased patient mortality [6]. Moreover,
the rate of new drug development is declining, leaving
few treatment alternatives for treating the increasing
burden of multi-resistant bacteria [7,8]. Since resistance
is especially prevalent in hospitals [9], various treatment
strategies have been suggested to facilitate better
responses to resistant infections and minimize the emer-
gence of new multi-resistant bacteria.
Three prominent strategies of antibiotic treatment are
cycling, mixing and combining. Under a cycling regime,
all the patients are treated with the same antibiotic drug
at a given time, and the drug used is periodically
switched. The rationale behind cycling is that each time
an alteration of drugs is administered, the pathogens
resistant to the previously used drug are attacked and
are hopefully susceptible to the new drug [10]. In the
mixing strategy, each patient receives a randomly
selected drug. This strategy can be viewed as the default
antibiotic usage within a hospital unit, when there is no
preference for any particular antibiotic. In such a case, if
two relevant antibiotics exist, approximately half the
patients receive each drug at any given time. Mixing has
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the advantage of creating a heterogeneous stress envir-
onment for the bacterial population [10]. At each trans-
mission, a bacterium has a probability of half
encountering a drug to which it has not recently been
exposed, and hence to which it is unlikely to be resis-
tant. Combining is the administration of several drugs
to each patient. By applying several antibiotics at once,
combining is designed to diminish the chance of evol-
ving resistance by eradicating any bacteria resistant to
just one type of antibiotics. As a result, more antibiotics
are used in combining than in mixing or cycling. This
could lead to higher antibiotic-related toxicity and
increased treatment costs [11].
Attempts to compare the different treatment strategies
and assess their relative efficiency have been made both
in empirical studies [12-17] and using theoretical analysis
[10,18-20]. All in all, results obtained using both
approaches have been inconclusive. It seems clear that
current models do not capture all the aspects of the phe-
nomenon, thus failing to properly distinguish between
scenarios favoring different treatment strategies. We sug-
gest that part of this shortcoming may result from the
simplifying assumption that resistance is acquired at a
constant rate, ignoring recent evidence to the effect of
environmental stress on the mechanisms of resistance
acquisition. The frequency of horizontal gene transfer
(HGT) and mutation was shown to increase when bac-
teria are under various stressors, including nutritional
deprivation, DNA damage, temperature shift, oxidative
stress and exposure to antibiotics [21-24]. An environ-
mental stressor especially relevant to our subject of
inquiry is antibiotics. In Streptococcus uberis, acquisition
of rifampin resistance through mutation was shown to
increase more than 1,000-fold under ciprofloxacin [25].
Interestingly, the rifampin resistant mutants showed no
resistance for ciprofloxacin, which indicates that this was
not merely the result of selection. It was also shown that
Pseudomonas aeruginosa increases its mutation rate by
up to 105 in the presence of tetracycline antibiotics, and
consequently obtains resistance to antibiotics [26].
Stress-induced mutation (SIM) might therefore have a
substantial influence on the dynamics of antibiotic resis-
tance acquisition [27-29]. In the context of HGT, Strepto-
coccus pneumoniae was shown to increase the rate of
chromosomal DNA uptake by transformation of a mar-
ker conferring resistance to streptomycin, when treated
with either streptomycin or norfloxacin [30]. It was also
shown that ciprofloxacin induces the transfer of the SXT
integrating conjugative element, which is known to
encode for antibiotic resistance genes, in SXT-containing
Escherichia coli and in Vibrio cholerae up to 300-fold
[31]. Phages were also observed to increase horizontal
transfer of genetic material as a reaction to their host’s
antibiotic-induced SOS response[32], a process which
might lead to an increased rate of antibiotic resistance
acquisition [33]. Theoretical work also supports stress-
induced genetic variation as a successful evolutionary
strategy [34-36] so this phenomenon might be even more
widespread then we currently know. Our goal is to
explore the impact of genetic variation induced by anti-
biotic stress on the spread of antibiotic multi-resistance
in a hospital unit. We use a classical modeling approach
(first described in [37]), modified to describe SIM and
stress-induced HGT. Our model is used to evaluate the
efficacy of each treatment strategy under different
assumptions regarding the effect of stress on genetic var-
iation. We find that stress-induced variation can indeed
alter the preferred treatment strategy.
Methods
Our mathematical model describes the dynamics of bac-
terial infections in a hospital unit. The bacterial pathogens
in question are assumed to accompany other ailments and
not be the main reason for hospitalization. We consider
two different antibiotic drugs, denoted antibiotic 1 and
antibiotic 2. The frequencies of patients infected with bac-
teria resistant to antibiotics 1 and 2 are R1 and R2 , respec-
tively, and the frequency of patients infected by
susceptible bacteria is S. The frequency of uninfected
patients is X . Clearance due to antibiotic usage occurs at
rate τ , and ci determines the fraction of patients receiving
antibiotic i. Resistance is assumed to be complete, so that
a patient infected by a bacterial strain resistant to drug 1
will not be affected at all by treatment with that drug.
Conversely, if treated with drug 2, the patient becomes
uninfected ( X ) at rate τ . g is the rate of spontaneous
clearance due to the response of the patient’s immune sys-
tem, b is the rate of bacterial transmissions resulting in
infection (for simplicity, superinfection is neglected), and




days). Since we assume the bac-
terial infection is not the main reason for hospitalization,
patients leave the hospital or die at a rate proportional to
their frequency. The proportion of infected patients enter-
ing the hospital is determined by λR1 , λR2 , λS for patients
carrying bacteria resistant to antibiotic 1, to antibiotic 2,
or to none, respectively. Uninfected patients enter the hos-
pital at rate m
(
1 − (λR1 + λR2 + λS)
)
, so hospital occu-
pancy is kept constant. All of the parameters representing
rates are given in units of day-1. We assume there are no
double-resistant bacteria in the hospital initially, and that
their frequency in the general population is negligible.
This scenario may reflect situations where newly devel-
oped antimicrobial agents have been recently introduced,
or were kept as the last resort, so that double resistance is
still scant.
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These parameters are incorporated in the following set
of ordinary differential equations:
dX
dt
= (1 − λS − λR1 − λR2 − X)m + (τ + γ )S + (τχ2 + γ )R1
+(τχ1 + γ )R2 − βX(S + R1 + R2)
dS
dt
= (λS − S)m − (τ + γ )S + βXS
dR1
dt
= (λR1 − R1)m − (τχ2 + γ )R1 + βXR1
dR2
dt
= (λR2 − R2)m − (τχ1 + γ )R2 + βXR2
(E1)
The equations describe the rate of change of patient
frequencies within a hospital. The dynamics are illu-
strated in Figure 1.
Equations E1 were solved analytically [See Additional
file 1, section 3], and by numerical integration using
Matlab® R2009a.
Moving average calculation: We used the numerical
solutions of equations E1 and the analytical computations
of double resistance emergence [See Additional file 1,
sections 1 and 2] to calculate values of a moving average.
First, the different sets of parameters are ordered accord-
ing to the parameter plotted on the × axis. Each point in
the plot presents the average double resistance emer-
gence over 201 equally weighted parameter sets: the one
corresponding to the point itself, the 100 nearest para-
meter sets with lower values of τ (
λR1
λR2
) , and the 100
Figure 1 Illustration of antibiotic resistance dynamics in a hospital setting. The solid lines represent infection, recovery and patient
turnover. Dashed lines represent the effects of HGT and mutation. Stress-induced genetic variation would result in an increased weight of the
dashed lines under antibiotic stress. X, S, R1, R2 are the frequencies of uninfected patients, patients infected with susceptible bacteria, and
patients with bacteria resistant to antibiotics 1 and 2, respectively. They enter the hospital with rates
(1 − λs − λR1 − λR2)m,λsm,λR1m,λR2m , and leave with a rate proportional to their frequency, where the patient turnover rate, m , is
the proportion constant. Infected patients turn uninfected either through spontaneous recovery due to the immune system (at rate g), or due to
antibiotic treatment (at rate τ). c1 and c2 determine which amount of antibiotics 1 and 2 are used, respectively. Uninfected patients become
infected at rate b multiplied by the frequencies of cleared and infected patients. R1,2 denotes the fraction of patients infected with double
resistant bacteria, assumed to be zero at the beginning. HGT, horizontal gene transfer.
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same 201 data sets are used to calculate double resistance
emergence for a given value of τ (
λR1
λR2
) under each of the
three strategies, resulting in a correlation between the
three values, and a similarity in the shape of the three
moving average curves (since the three means are taken
over the same parameter sets).
Results
Stress-induced mutation
Considering stress-induced mutation, we define μs and
μr as the rates of mutations conferring antibiotic resis-
tance when bacteria are under antibiotic stress and
when they are free of antibiotic stress, respectively. We
assume that mutation is increased by stress, that is, μs
>μr. Our work concentrates on the scenario where sen-
sitive bacteria (corresponding to host frequency S ) have
a negligible contribution to the generation of single
resistant bacteria. In terms of our dynamics, this trans-
lates to the following inequality:
μsS  λRlm + βXRi, i = 1, 2 (C1)
Intuitively, inequality C1 is satisfied due to either
abundance of single resistance in the population outside
the hospital, causing high entrance rates of single resis-
tant bacteria, or abundance inside the hospital due to
infection and selection.
An important feature of antibiotic resistance is its per-
sistence within a host without direct selective forces for
long periods of time [38]. Direct selection occurs when
a patient is treated with a certain antibiotic, say antibio-
tic 1, and a new bacterium resistant to antibiotic 1 arises
within the host, by mutation or HGT. Thus, due to
strong selection for antibiotic resistance, it has a high
probability of taking over the entire infecting population
and turning the host to R1. When the host is not treated
with antibiotic 1, resistance to antibiotic 1 might not
confer any direct fitness advantage. Thus, we assume
that the probability of a bacterium to take over the
infection in the second scenario is s times the chance in
the first scenario, where 0 < s < 1 represents the relative
persistence of antibiotic resistance when there is no
direct antibiotic usage. Under condition C1, we can con-
sider s only when computing within-host dynamics of
double resistant bacteria.
The exact value of s is hard to measure, but is likely
to be non-zero, as evidence suggests that patients who
have not been treated with antibiotics for periods of up
to three years still carry antibiotic resistant bacteria [6] .
One reason for high persistence of resistant bacteria in
ambulatory patients and medical staff might be residuals
of antibiotics that are found in the environment at
amounts sufficient to change the fitness of sensitive bac-
teria. This might often be the case in hospitals, as it was
shown that even very low concentrations of antibiotics
can select for antibiotic resistant bacteria [39] and that
even ambulatory patients who have not received antibio-
tics for long periods of time harbor high frequencies of
antibiotic resistant bacteria [40].
To compute the emergence of double resistance
through mutation we first define a term describing the
sum of the frequencies of patients carrying single resis-





Using ESIM and the parameters described above, we
can now write a term describing the emergence of dou-
ble-resistant bacteria under treatment strategy U. It will
be denoted by ξSIM (U ). Writing ξSIM explicitly for the
three strategies results in the following expressions [See




(μs + μrσ )ESlM(mixing),
ξSIM(combining) = μsESIM(combining)
For cycling we have a more complex expression. We
will divide time into segments in which only one anti-
biotic is applied. In each of these segments only one
strain of resistant bacteria is under antibiotic stress.
Thus,
ξSIM (cycling ) = μsA + μr s B where A = ∫ Ri (cycling)
when antibiotic j ≠ i is applied and B = ∫ Ri (cycling)
when antibiotic i is applied [See Additional file 1, sec-
tion 2, definition (9)]. This allows us to prove that as
μs
μr
increases, emergence of double resistance in cycling
decreases relative to the emergence of double resistance
in mixing and combining [See Additional file 1, section
2.1, equations 11-12]. This is shown in Figure 2, where
emergence of double resistance by mutation for each
strategy is plotted as a function of
μs
μr
. Dashed and solid
lines correspond to s = 0 and s = 1. Double resistance
emergence is monotonically increasing in s [See Addi-
tional file 1 section 2, equations 7, 10], thus the values
for intermediate values of s are between the two curves.
Some intuition about the relative success of cycling can
be obtained from looking at the fraction of stressed bac-
teria under each strategy: under the combining strategy,
all bacteria are under antibiotic stress; under the mixing
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strategy half of the bacteria of each resistant strain will
be under antibiotic stress; cycling has the advantage that
a resistant strain of bacteria will be under antibiotic
stress only at certain periods of time - when all patients
are receiving the antibiotic to which this strain is sensi-
tive. During these periods the hyper-mutating strain
would typically be at low frequency. This causes the
increase in double resistance emergence due to SIM to
be more moderate under cycling than under mixing or
combining. Persistence of antibiotic resistance,s , also
has a strong influence on the dynamics: s and μr appear
in our equations only within a single term s · μr , thus




effects on the dynamics. The special case where we
assume no stress induction and s = 0 was previously
studied by Bonhoeffer et al. [19] and our results are
consistent with theirs. However, our conclusions hold
for intermediate values of s as well, assuming mutation
rates are sufficiently dependent on stress.
In addition to the parameters pertaining to the stress
induction mechanisms and within-host selection, the
parameters determining ESIM also play an important role
in the emergence of double resistance. To test the
robustness of our model to changes in these parameters
we study the emergence of double resistance for 104
random sets of parameters. The values of m were cho-
sen from a generalized extreme value distribution fitted




, were chosen from a uni-
form distribution on [2,14] (deduced from optimal treat-
ment estimations in [42]). Spontaneous clearance, g, is
then chosen from a uniform distribution on [0,τ] , and
Infection rates, b, were chosen from a log uniform dis-
tribution on [0.001,1] [10]. Four more values were cho-
sen from the uniform distribution on 0[1], and then
normalized to determine the entrance frequencies
λs,λR1 ,λR2 , 1 − λs − λR1 − λR2 .
In Figure 3 we plot the value of a moving average (see
Methods) of the emergence of double resistance, where
the horizontal axis is taken as the rate of clearance due
to antibiotic usage (τ ). The moving average of double
resistance under mixing is plotted in green, under
cycling in blue, and under combining in red. When the
values of the moving average for mixing and cycling are
Figure 2 Emergence of double resistance as a function of the effect of stress on mutation. The double resistance emergence for each
strategy is plotted, in log scale, as a function of
μs
μr
, which varies from 1 to 50. Note that lower emergence values indicate higher efficiency of
the strategies. Mixing is plotted in green, cycling in blue, and combining in red. Double resistance emergence is monotonically increasing in s
(persistence of antibiotic resistance), so curves with intermediate values of s will be within the boundaries of the curves s = 0 and s = 1
displayed. The value of s is irrelevant for combining, so only one curve is produced. An intersection of the curves implies that the preference




the most efficient strategy. When s is low enough, cycling is the most efficient strategy even without SIM. The emergence is taken over 600
days. The length of each cycle in the cycling strategy is 200 days. Other parameter values: b = 0.9, g = 0.03, m = 0.1, ls = 0.1, λR1 = 0.1 ,
λR2 = 0.1 , τ = 0.5. SIM, stressed-induced mutation.
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very close, only the blue curve is visible. Two values of
the persistence of antibiotic resistance,s, are presented:
s = 0.1(panels A, C) and s = 1 (panels B, D). Cycling
outperforms the other strategies given even a moderate
influence of stress on mutation rates, or a low enough
value of s. As τ increases, combining becomes slightly
more effective (as it reduces single resistance frequency
efficiently) but the effect is weak. Whenever mutation is
stress-induced, or s has a low value, combining would
be the least efficient strategy in terms of inhibiting
emergence of double resistance.
Different results are obtained when observing the
mean proportion of infected patients rather than double
resistance emergence. Figure 4 shows the mean fre-
quency of infected patients in the hospital, for the same
random sets of parameters as in Figure 3 (note that
under condition C1, any changes in parameters affecting
stress-induction are irrelevant). We can see that com-
bining always outperforms cycling and mixing in terms
of minimizing overall infected patients. When antibiotic
resistance persistence,s , is high and mutation is not
stress-induced, combining reduces both infection and
emergence more efficiently than the other strategies
(Figure 3.B), but only by a few percent. However, under
stress-induced mutation, or low values of s, there is a
conflict between minimizing infection and minimizing
Figure 3 Robustness of the dynamics describing resistance acquisition by mutation. The dynamics describing double resistance
emergence by mutation were studied for 104 random sets of parameters (derived from the distributions described in the main text). The
moving average of the emergence of double resistance (see methods) is plotted as a function of the rate of clearance due to antibiotic usage
(τ). Note that the same data sets are used for a given value of τ under each of the three strategies, generating an association between the
curves. The moving average of mixing is plotted in green, of cycling in blue, and of combining in red. When the values of the moving average
for mixing and cycling are very close only the blue curve is visible. (A)
μs
μr
= 1, s = 0.1. When s is low, cycling decreases the emergence of
double resistance better than the other strategies even with no influence of stress on mutation rates. (B)
μs
μr
= 1, s = 1. When s is high and
stress has no effect on mutation, combining is more efficient than the other strategies. (C)
μs
μr
= 10, s = 0.1. At low s, increased influence of




= 10, s = 1. At high s, increase in mutation rates due to stress alters the preferred strategy drastically from combining
to cycling (compare with B).
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emergence of resistance: combining reduces the propor-
tion of infected patients by about 1% on average, but
increases emergence of double resistance by more than
50% (see Figure 3 and Additional file 1 table S1). Simi-
larly, when s is high and mutation is not stress-induced,
mixing slightly reduces both infection and emergence in
comparison with cycling (Figure 3.B and Additional file
1, table S1). Under stress-induced mutation, or low
values of s, there is a conflict: mixing reduces the pro-
portion of infected patients (by about 0.1% on average),
but increases emergence. For a large subspace of realis-
tic parameter sets [43] double resistance is substantially
decreased under cycling, relative to mixing, under the
assumption of SIM [See Additional file 1, Figure S1].
The clearance rate due to antibiotic usage,τ, mildly
decreases both infection (Figure 4) and resistance emer-
gence (Figure 3). As the clearance rate increases, bac-
teria are eliminated more efficiently, thus the window of
opportunity for infecting bacteria to acquire double
resistance narrows.
Stress-induced horizontal gene transfer
Another mechanism for acquiring antibiotic resistance is
HGT. Acquiring antibiotic resistance through HGT is a
process that depends on the rate of encounters between
bacteria of different resistant strains, and on the prob-
ability of bacteria to donate and receive genetic material.
Bacteria of one strain will encounter bacteria of another
strain at a rate proportional to the amount of interac-






For the rate of encounters between bacteria of differ-
ent resistant strains we multiply EHGT(U) by a constant
C, which denotes the rate of bacterial transmission from
one patient to another (by hospital staff, direct contact,
and so on). We denote by d the probability that bacteria
will donate genetic material, and by r the probability
that bacteria will receive genetic material, given that a
bacterial transmission event has occurred. The probabil-
ity of successful HGT between bacteria, given bacterial
transmission, is thus r · d . However, when stress-
induced HGT is considered, r and d are no longer con-
stant, as different treatment strategies create varying
levels of stress for different bacteria. We will define rr,
dr to be the probabilities of receiving and donating
genetic material for bacteria which are not under anti-
biotic stress. Similarly, rs and ds will be the probabilities
of receiving and donating genetic material for bacteria
which are under antibiotic stress. For example, if all
patients are treated with the same drug, bacteria resis-
tant to that drug would perform HGT with probabilities
Figure 4 Robustness of the dynamics describing proportion of infected patients. The dynamics described in E1 were studied for 104
random sets of parameters (derived from distributions described in the main text). The moving average of the emergence of double resistance
(see Methods) is plotted as a function of the rate of clearance due to antibiotic usage (τ). Note that the same data sets are used for a given
value of τ under each of the three strategies, generating an association between the curves. The moving average of mixing is plotted in green,
of cycling in blue, and of combining in red. When the values of the moving average for mixing and cycling are very close, only the blue curve is
visible. We can see that combining is the most efficient strategy in reducing the proportion of infected patients. When the rate of clearance due
to antibiotics, τ, increases, the relative efficiency of combining increases , while the proportion of infected patients decreases.
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r r and d r , while bacteria sensitive to it would perform
HGT with probabilities r s and d s . Stress-induced HGT
will be expressed by the conditions r s >r r and d s >d r .
Note that when different patients are treated with dif-
ferent types of antibiotics, bacteria may be transported
from a non-stressful environment to a stressful one and
vice versa. j will represent the time required for the cel-
lular mechanisms to induce or repress HGT. Namely,
when j = 0 a change in the bacteria’s well-being is
immediately translated to a change in HGT rates,
whereas for larger values of j the stress-induction
mechanisms react more slowly to changes in environ-
mental stress. We define the extreme case of j = 1 as
the case where the HGT rates of bacteria transmitted
from patient A to patient B depend only on the stress
the bacteria experienced while residing in patient A. In
analogy to inequality (C1), we concentrate on the case
where the influence of non-resistant bacteria on the
emergence of double resistance is negligible. This can
be formally expressed as:
CdsrsSR  λRlm + βXRi, i = 1, 2 (C2)
Using the parameters and assumptions described
above, we denote by ξHGT (U) the emergence of double-
resistant bacteria through stress-induced HGT under
treatment strategy U, and derive ξHGT for each of the
strategies [See Additional file 1, section 1, equations 1-
3]. The combining strategy is the simplest to model,
since all patients are treated with at least one effective
antibiotic. Therefore, the emergence of double resistance
under combining is
ξHGT(combining) = CrsdsEHGT(combining).
Emergence under cycling can be broken into time
intervals in which only one drug is used. Assuming





(rrdsσ + rsdrσ + rrds + rsdr)EHGT(cycling).
Note that for both combining and for cycling, j does
not appear in the term describing double resistance
emergence, since under both strategies bacteria will not
experience an environmental change when transported
from one patient to another. For mixing, the heteroge-
neity of the environment due to the usage of different




[rs(dsφ + dr(1 − φ)) + rrdsσ + rsdr + rr(drφ + ds(1 − φ))σ+
ds(rsφ + (1 − φ)rr) + dsrr + drrsσ + dr(rrφ + rs(1 − φ))σ ]EHGT(mixing)
Analysis of ξHGT for each strategy shows that high








will cause the ratio
ξHGT(cycling)
ξHGT(combining)
to be arbitrarily close to zero [See
Additional file 1, section 1.1, equation (6)]. In other
words, the more HGT becomes affected by stress in
both the donor and the recipient ends, the more effi-
cient cycling becomes relative to combining. This occurs
due to the fact that when cycling is applied only one
type of resistant bacteria is stressed at any given time.
For double resistant bacteria to emerge through HGT, a
donor and a recipient of different resistance types are
needed, but under cycling they will never be simulta-
neously under stress. In contrast, when the combining
strategy is applied all bacteria are stressed, including
potential donors and recipients alike.
The efficiency of the mixing strategy depends on j.
This results from the fact that under mixing, different
patients are treated with different drugs. When j is low,
bacteria transported from one patient to another change
their HGT probabilities according to the drug taken by
the new host. Therefore, for both mixing and cycling,
bacterial HGT events which produce double resistance
will rarely occur when both donor and recipient are
stressed. In contrast, when j is high, bacteria trans-
ported from one patient to another retain HGT prob-
abilities complying to the antibiotic treatment of their
former host, allowing the emergence of double resis-
tance through HGT in which both donor and recipient
are stressed.
















the dominant factor in the dynamics [See Additional file
1, section 1.1 equations 4-6], and in order to avoid
assumptions about the role of donor and recipient in
















Figure 5 shows the rate of double resistance emer-
gence for each strategy as a function of θ. We can see
that the rate of double resistance emergence depends
also on j (compare panels A and B of Figure 5), and to
a lesser extent on s (dashed and solid curves in each
panel correspond to s = 1 and s = 0 , respectively).
The ability of a strategy to minimize EHGT plays an
important role in the emergence of double resistance
through HGT as well. Since the dynamics determining
EHGT are complex we will focus only on several impor-
tant factors. First, we note that when the cycle length
approaches zero, double-resistance emergence under
cycling converges to double-resistance emergence under
mixing, as was shown in [10]. Second, when there is
strong asymmetry between the frequencies of different
single resistant bacterial infections, cycling performs
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poorly. If the current drug used is ineffective against the
bacterial strain with the high entrance rates it will allow
the incidence of that strain to increase rapidly. This was
shown by Bergstrom et al. [10], who predicted that
under high asymmetry of single resistance entrance
rates cycling would not be an efficient strategy. While
this is true for a model assuming constant HGT, we
argue that when HGT is stress-induced, and the
response to environmental changes is not immediate
(that is, j > 0 ), cycling can still be the most efficient
strategy. When the response is immediate, mixing will
tend to minimize double resistance emergence best.
Combining will rarely minimize double resistance better
than the other two strategies when HGT is stress
induced. These conclusions were obtained by studying
two prominent factors that influence the emergence of
double resistance: the ratio of entrance rates [See Addi-
tional file 1, section 3] and the effect of stress on HGT.
We have randomly selected 104 parameter sets (the
same parameter sampling as in Figure 3) and for each
parameter set computed the moving average of the
emergence of double resistance by HGT for the three




log scale). The moving average of mixing is plotted in
green, of cycling in blue, and of combining in red.
When the values of the moving average for mixing and
cycling are very close, only a blue curve is visible. We
can see that when HGT is completely unaltered by
stress, the relative efficiency of the strategies depends on
the persistence of antibiotic resistance:s . When s is
high, combining is the best strategy at minimizing dou-
ble resistance for most parameter sets (Figure 6.B).
However, when s decreases, mixing becomes a promi-
nent strategy as well, with cycling close behind it (Figure
6.A). In Figure 6.C and 6.D, we allow mild stress
induced HGT and take θ = 10. s has a lesser influence
when HGT is stress-induced [See Additional file 1,
Figure 5 Emergence of double resistance as a function of the effect of stress on HGT. Double resistance emergence for each strategy is
plotted, in log scale, as a function of θ, the effect of stress on HGT. Mixing is plotted in green, cycling in blue, and combining in red. We see
that stress-induced HGT changes the efficiency of the strategies so that cycling is the most efficient strategy for a wide range of θ values - note
that lower emergence indicates a more efficient strategy. Panel A shows results for j = 1, whereas in panel B j = 0. We can see that the
double resistance emergence for mixing indeed increases dramatically for j = 1 in comparison with j = 0 , matching the intuitive explanation
(see text). An intersection of the curves implies that the preference between two strategies should change. The mean is taken over 600 days,
where the length of each cycle in the cycling strategy is 200 days. Other parameter values: b = 0.9, g = 0.03, m = 0.1, ls = 0.1, λR1 = 0.1 ,
λR2 = 0.1 , τ = 0.5, C = 1 (note that changing C will just rescale the horizontal axis, so its value is arbitrary). HGT, horizontal gene transfer.
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section 1.1] and, therefore, we set it at an intermediate
value of s = 0.5 . Cycling and mixing now become more
efficient strategies than combining. We can also see the
influence of j on whether cycling or mixing will be the
most efficient strategy in terms of inhibiting double
resistance emergence (The influences of other para-
meters are shown in Figure S2 in Additional file 1).
As we mentioned above, combining always outper-
forms cycling and mixing in terms of minimizing overall
infected patients, but the benefit is of only a few percent
(Figure 4 and Additional file 1, table S1). When antibiotic
resistance persistence,s, is low, even without stress
induction, emergence of double resistance under com-
bining is higher by 30% than under other strategies [See
Additional file 1, table S1]. When stress induction is sig-
nificant, double resistance emergence under combining is
more than tenfold higher than under cycling, and more
than 30% higher than under mixing (Figure 6 and Addi-
tional file 1, table S1).
Discussion
Several conclusions can be derived from our mathemati-
cal model. We have shown that stress-induced genetic
variation can have a drastic influence on the emergence
of double resistance, and should be considered when
deciding on a hospital wide strategy of antibiotic usage.
Although always slightly more efficient than other stra-
tegies in decreasing the incidence of single resistant
infections, the strategy of combining performs very
poorly in inhibiting double resistance emergence when
genetic variation is stress-induced. This holds true
despite the fact that under the combining strategy all
patients receive effective treatment, and even though we
disregard the toxic effects of combining antibiotics for
Figure 6 Robustness of the dynamics describing resistance acquisition by HGT. The dynamics describing double resistance emergence by
HGT were studied for 104 random sets of parameters (derived from distributions described in the main text). The moving average of the
emergence of double resistance (see Methods) is plotted as a function of the entrance rates’ ratio (
λR1
λR2
). Note that the same data sets are used
for a given value of
λR1
λR2
under each of the three strategies, generating an association between the curves. The emergence rate under mixing is
plotted in green, under cycling in blue, and under combining in red. When the emergence rates under mixing and cycling are very close, only
the blue curve is visible. In (A) and (B), HGT is not affected by stress at all (θ = 1) so the delay of stress-induction mechanisms (j) is irrelevant. In
contrast, persistence of antibiotic resistance (s) is influential in such cases, and we present two extreme values. (A) θ = 1,s = 0.1. Cycling and
mixing are the dominant strategies, where their relative efficiency decreases at asymmetric entrance rates. (B) θ = 1, s = 1 . Combining is the
preferred strategy for inhibiting double resistance emergence. In (C) and (D) HGT is stress induced with θ = 10, so while j is now an influential
parameter, the effect of s is very minor (Additional file 1, section 1) and we present only the value s = 0.5. (C) θ = 10, j = 1, s = 0.5 . Mixing is
slightly more preferable than cycling, and cycling is most inefficient when entrance rates are asymmetric. (D) θ = 10, j = 0, s = 0.5 . Cycling is
the preferred strategy for inhibiting double resistance emergence. HGT, horizontal gene transfer.
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the patient and the economic burden it carries for the
population [11,44].
Cycling is the preferred strategy with respect to the
acquisition of resistance through SIM. Low persistence of
antibiotic resistance (s) further amplifies the effects of
SIM and increases the relative efficiency of cycling. In the
presence of stress-induced HGT, cycling and mixing are
the favored strategies, and the preference between them
is determined by how fast the bacteria respond to envir-
onmental changes (the parameter j in our model). If
changes in HGT frequencies in response to antibiotic
stress are rapid, mixing is the preferred strategy, whereas
slow response to stress would tilt the scales in favor of
cycling. We should note that our predictions hold even
for a very mild increase of HGT and mutation rates
under antibiotic stress (Figures 3 and 6) in comparison
with those described in the literature [25,26,30,31].
Higher dependence of variation on stress leads to results
which are more robust to changes in other parameter
values.
There are several criteria which are used to evaluate the
efficiency of an antibiotic strategy: reduction of total infec-
tion burden; single resistance minimization; and inhibition
of multiple resistance emergence [10,19,20,43,45,46]. We
compared two measures of treatment efficiency: propor-
tion of infected patients and emergence of double resis-
tance. The latter is of interest mainly in a population
where double resistance bacteria are still at a low fre-
quency, thus we focused on that scenario. There is rarely a
strategy which is ideal for both infection and emergence of
double resistance at the same time. A strategy that is suc-
cessful at reducing infection applies more accurate treat-
ment, and this has two effects on emergence: on the one
hand, eliminating infection and thus minimizing the bac-
teria that would become resistant. On the other hand,
treatment creates selective pressure and potentially stress
induced variation - two factors that might lead to a faster
generation of resistance. We find that combining always
outperforms mixing and cycling by a small amount, when
it comes to minimizing infection. When considering
double resistance emergence, both mixing and cycling out-
perform combining substantially when variation is stress-
induced. This contrast should be taken into account when
deciding on a treatment strategy.
We make several assumptions that should be discussed
explicitly. First, we did not consider the possible fitness
cost of antibiotic resistance. This is consistent with
recent evidence suggesting that compensatory mechan-
isms reduce such cost to a low level [27,47,48]. Addition-
ally, for stress-induced HGT to have substantial influence
on the dynamics we require that both donor and recipi-
ent probabilities of HGT would increase with stress. It
was shown in [30] that acquisition of resistance through
transformation increases with the recipient’s stress. The
amount of genetic material available for transformation
in the environment is influenced by the death of bacteria,
and is therefore dependent on the stress that the donor
bacteria experience. This is particularly true when phages
cause lysis of their host when the host is stressed [32,33].
Similarly, donation and acquisition of conjugative ele-
ments were each, separately, shown to increase under
stress [31,49,50]. Another issue we did not address is the
influence of stochastic events on the dynamics. The
population size within a hospital unit might be small
enough for stochastic events such as epidemic outbursts
of bacteria and extinction of rare bacterial strains for
long periods of time, to be very influential [45]. Human
errors in the form of dosage errors, lack of compliance to
hospital guidelines and so on can be another source of
stochastic noise that might shift the dynamics from the
deterministic expectation described here.
Furthermore, the values of certain parameters might be
different for different patients. For instance, elderly
patients might be more susceptible to bacterial infections
than other patients [51,52]. This could be expressed by
modeling compartments of patients with different para-
meter values (in this example, higher b values) in accor-
dance with the epidemiological data. Finally, the relative
efficiency of the different drugs was assumed to be equal,
and no drug interactions were considered - two factors
that may further affect the evolution of resistance [53].
Future work could address these matters explicitly.
Our model points to several directions in which
empirical data can guide the planning of efficient treat-
ment strategies. First, it is important to understand
whether a pathogen acquires resistance primarily through
mutation or through HGT. Second, it is important to
estimate the persistence of antibiotic resistant bacteria
within hosts not currently treated with antibiotics effec-
tive against those bacteria (the parameter s in our
model). Finally, we would like to directly assess the
degree to which stress, and in particular antibiotic stress,
increases the rates of bacterial mutation and HGT.
Obtaining such data would be an important step in the
ongoing struggle against multi-drug resistance. We
believe that obtaining such precise data will help to
decrease the prevalence of multiple resistance strains in
bacterial pathogens which have already shown to increase
genetic variation under stress, such as P. aeruginosa, S.
pneumoniae, E. coli and V. cholerae [26,30,31].
Conclusions
In conclusion, our work presents an important factor
thus far overlooked when planning antibiotic treatment
strategies, namely the effect of stress on genetic variation.
We show that considering the effects of stress-induced
genetic variation alters the results of existing theoretical
models: specifically, combining antibiotics may result in
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an increased rate of emergence of double resistant bac-
teria, whereas cycling antibiotics can be more effective
than previously thought. Applying our predictions to spe-
cific pathogens would require better empirical evaluation
of a few key parameters that affect the dynamics of dou-
ble resistance emergence. We make specific predictions
regarding the parameter values that would favor particu-
lar treatment strategies, suggesting that further investiga-
tion of stress-induced variation and its mechanisms
might have crucial importance for combating multiple
antibiotic resistance.
Additional material
Additional file 1: Proofs and additional figures and tables. Additional
file 1 contains proofs for all the equations presented in the main text. It
also contains two additional figures presenting the relative efficiency of
inhibiting double resistance emergence for the mixing and cycling
strategies (Figures S1 and S2), and a table comparing the mean
frequency of overall infected patients, taken over various parameter sets,
for all three strategies (Table S1).
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